In addition, given that HDAC6 inhibitors are undergoing clinical studies for certain diseases, the data shown in this study suggest an importance for investigating the effectiveness of HDAC6 inhibitors for pancreatic cancer treatment. This evidence concerns the gene HDAC6 and familial pancreatic carcinoma.